FDA Approves DNA-Based Test to Determine Blood Compatibility
The molecular test is the first of its type approved to report genotypes as final results.
Read More
Search Results for: genetic testing
Study Identifies Payor Savings for Treating Psychiatric Disorders
A study based on OptumInsight data showed more than $6000 in savings in first-year healthcare costs compared to treatment-as-usual for patients with depression.
Read More
Precipio Launches HemeScreen Molecular Test for Hematologic Cancers
The test challenges a $100 million annual US laboratory market by reducing costs through a simple, screening assay.
Read More
Determining Molecular Response in Chronic Myeloid Leukemia
Droplet digital PCR can provide a more accurate assessment of low levels of BCR-ABL mRNA than quantitative real-time PCR.
Read More
FDA Recommendations on the Use of Genetic Testing
In a safety communication issued at the beginning of November 2018, FDA alerted patients and healthcare providers that many claims about the ability of direct-to-consumer pharmacogenetic tests to predict a patient’s response to specific medications have not been reviewed by the agency, and may not be supported by scientific or clinical evidence for most medications.
Read More